Policy Institute
Articulate the value of medical innovation and ensure patient access to therapies
Our policy focus
Medical innovation
We strive to educate the public on the value of drug development to support increased innovation. In addition, we seek to incentivize development of less marketable treatments
Patient access
We ensure equitable access to quality treatment for patients around the world and strive to increase access to early diagnosis and detection
RTWCF rare disease advisory board
We’ve assembled an advisory board to help guide us on priority areas and co-create opportunities for education, policy, and funding to support rare disease communities.
Insight
Post-launch, pre-cliff: The R&D congress ignores
Contact us for information on open grants and how to apply
